3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
3
Inflammation
2
Glioblastoma
2
Frailty
2
Recurrence
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myofibroma
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hemorrhage
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anemia
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
pembrolizumab
5
Nivolumab
3
Cisplatin
3
Taxes
2
Paclitaxel
2
poly ICLC
1
fludarabine phosphate
1
fludarabine
1
abemaciclib
1
Risk Factors
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Pemetrexed
1
Nimorazole
1
Injections
1
High-Intensity Focused Ultrasound Ablation
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Biological Products
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Squamous Cell
×
Ascorbic Acid
×
1 year
×
Clear all
No trials found.